DRAVET SYNDROME FOUNDATION INC: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
DRAVET SYNDROME FOUNDATION INC (EIN 27-0924627)
Tax period
2022-01-01 to 2022-12-31
Filed
2023-04-17
IRS object ID
202301089349300125
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-04-17T14:28:37-07:00ReturnTs
Tax Period End2022-12-31TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2022-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN270924627EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DRAVET SYNDROME FOUNDATION INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlDRAVBusinessNameControlTxt
Phone2033921955PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO Box 3026AddressLine1Txt
CityCherry HillCityNm
State AbbreviationNJStateAbbreviationCd
ZIP08034ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonTed OdlaugPersonNm
Person TitlePresidentPersonTitleTxt
Phone2033921955PhoneNum
Signature2023-04-17SignatureDt
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer1TrustedCustomerCd
OOB Security Verification11OOBSecurityVerificationCd
Last Submission Rqr OOB1LastSubmissionRqrOOBCd
Authentication Assurance LevelAAL2AuthenticationAssuranceLevelCd
Profile Password ChangeYes (X)ProfilePasswordChangeInd
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerTed OdlaugPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO Box 3026AddressLine1Txt
CityCherry HillCityNm
State AbbreviationNJStateAbbreviationCd
ZIP08034ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$2,733,455GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.dravetfoundation.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2009FormationYr
Legal Domicile StateCTLegalDomicileStateCd
Activity Or MissionThe mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families.ActivityOrMissionDesc
Voting Members Governing Body8VotingMembersGoverningBodyCnt
Voting Members Independent8VotingMembersIndependentCnt
Total Employee7TotalEmployeeCnt
Total Volunteers50TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,437,446PYContributionsGrantsAmt
CY Contributions Grants$1,713,227CYContributionsGrantsAmt
PY Program Service Revenue$693,507PYProgramServiceRevenueAmt
CY Program Service Revenue$662,596CYProgramServiceRevenueAmt
PY Investment Income$5,151PYInvestmentIncomeAmt
CY Investment Income$88,364CYInvestmentIncomeAmt
PY Other Revenue$49,908PYOtherRevenueAmt
CY Other Revenue$51,595CYOtherRevenueAmt
PY Total Revenue$2,186,012PYTotalRevenueAmt
CY Total Revenue$2,515,782CYTotalRevenueAmt
PY Grants And Similar Paid$444,058PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$693,698CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$468,578PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$503,705CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$79,018CYTotalFundraisingExpenseAmt
PY Other Expenses$352,687PYOtherExpensesAmt
CY Other Expenses$831,436CYOtherExpensesAmt
PY Total Expenses$1,265,323PYTotalExpensesAmt
CY Total Expenses$2,028,839CYTotalExpensesAmt
PY Revenues Less Expenses$920,689PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$486,943CYRevenuesLessExpensesAmt
Total Assets BOY$5,918,927TotalAssetsBOYAmt
Total Assets EOY$6,249,148TotalAssetsEOYAmt
Total Liabilities BOY$592,323TotalLiabilitiesBOYAmt
Total Liabilities EOY$488,374TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$5,326,604NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$5,760,774NetAssetsOrFundBalancesEOYAmt
MissionThe mission of the Dravet Syndrome Foundation is to aggressively raise funds for Dravet syndrome & related epilepsies; support & fund research; increase awareness; & provide support to affected individuals & families. We understand the ongoing need to fund innovative research, the urgency in finding better treatments, the motivation of our donors to make an impact specifically in the fields of Dravet syndrome and related epilepsies, the importance of transparency and accountability of not only our organization, but the researchers that we fund, and the need for global collaboration in order to find a cure.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$852,551ExpenseAmt
Grant$667,345GrantAmt
Revenue$10,000RevenueAmt
DescDSF funds research for better treatments and a cure for Dravet syndrome and related epilepsies by awarding research grants to qualified scientists and clinicians. These grants fund initial research hypotheses that have not been fully explored. The results extracted from this type of research will help bring untested research to the point that it can qualify for larger governmental funding. Since 2009, DSF has awarded over $6.4 million to 56 research endeavors. Research areas include SUDEP, gene therapy, drug discovery, screening, treatments, genetics, epidemiology and neuronal networks. In 2020, DSF hired a Scientific Director to serve as the liaison between the medical/scientific community and DSF, developing strategies to support research, manage DSF's involvement in projects, and move projects forward with assistance in project management, manuscript preparation, and other writing opportunities. The Scientific Director acts as a representative of DSF to other institutions including NIH, PDA, pharma and biotechnology companies.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$631,500ExpenseAmt
Grant$26,353GrantAmt
Revenue$503,096RevenueAmt
DescReceiving a diagnosis of Dravet syndrome (DS) can be overwhelming and may leave a family with many unanswered questions. DSF produces a biennial professional and family conference designed to unite community stakeholders to address these questions - families, caregivers, clinicians, researchers, and other professionals. Our 2022 conference welcomed over 300 parents, children and professionals. The 3-day event featured over 30 speakers who presented on current research, co-morbidities, best care practices, and daily living challenges. In 2017 the DSF Family Network was established to provide regional support to families. As part of this initiative, 5 educational workshops are held across the country on odd-numbered years, opposite of our biennial conference. These workshops are a time for patients and their families to come together to learn about research and treatment options, connect with others in their region, and be a part of DSF's shared vision for a better outcome for those affected by DS. In addition to these conferences and workshops, DSF has established an international patient assistance grant program to help patients receive medical equipment, therapy devices, and education aides associated with DS that are not covered through private insurance or other assistance programs. Since 2009, DSF has awarded over $222k in assistance to families. On February 3, 2022, DSF held an Externally-Led Patient-Focused Drug Development meeting on DS. This meeting was a long-awaited opportunity for our patient community to educate representatives of the FDA and pharmaceutical companies, as well as academic researchers and clinicians, about the challenges that individuals living with DS face daily. Our objective was to give patient families a platform to share what it means to have a DS diagnosis, which symptoms should be prioritized, and how this disease impacts the quality of life for the patient and family so that the FDA and pharmaceutical companies can understand the patient experience.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$154,497ExpenseAmt
Grant$0GrantAmt
Revenue$149,500RevenueAmt
DescDSF produces an annual research roundtable meeting to provide opportunity for researchers and clinicians to collaborate and discuss better treatment options and a roadmap toward a cure and how to best facilitate both. This meeting started in 2010 as a brainstorming session for the few researchers working on Dravet syndrome (DS). DSF hosted its 13th annual Research Roundtable, and had our largest attendance yet, with over 200 participants. In 2022, DSF developed a professional education video series to highlight the latest guidelines in clinical care. The development of this updated professional educational series was prompted by the recent publication of the International Treatment Consensus on Diagnosis and Management of Dravet Syndrome. Also in 2022, DSF invited adult neurologists with an interest in learning more about DS to attend a meeting focused specifically on how to better support families through the transition from pediatric to adult care.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$0TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$1,638,548TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment0ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To IndividualsYes (1)MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document13IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee7EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Form8899 Filedind0Form8899Filedind
Form1098 C Filed0Form1098CFiledInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members8GoverningBodyVotingMembersCnt
Independent Voting Member8IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEO0CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonJamie CohenPersonNm
Phone2033921955PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1522 Mackin DriveAddressLine1Txt
CityCherry HillCityNm
State AbbreviationNJStateAbbreviationCd
ZIP08002ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
Mary Anne Meskis
Executive Director400Yes (X)$155,000$0$0
Veronica Hood
Scientific Director400$151,200$0$0Yes (X)
Jamie Cohen
Chief Financial Officer400Yes (X)$88,560$0$0
Kate Hintz
President10Yes (X)$0$0$0Yes (X)
Ted Odlaug PhD
Vice President10Yes (X)$0$0$0Yes (X)
Josh Goldman
Treasurer10Yes (X)$0$0$0Yes (X)
Tim Wood
Past Treasurer10Yes (X)$0$0$0Yes (X)
Ross Nicholas
Secretary10Yes (X)$0$0$0Yes (X)
Nathan Batt
Trustee10$0$0$0Yes (X)
Claire Carey
Trustee10$0$0$0Yes (X)
Ashley Kerns
Trustee10$0$0$0Yes (X)
Joseph Sullivan MD
Trustee10$0$0$0Yes (X)
Jenny Tischer
Past Trustee10$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$394,760TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$0TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K2IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Geben CommunicationBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line1143 E Main St 200AddressLine1Txt
CityColumbusCityNm
State AbbreviationOHStateAbbreviationCd
ZIP43215ZIPCd
FieldValueIRS element (for citing)
ServicesPublic RelationsServicesDesc
Compensation$177,100CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Federated Campaigns$0FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$741,106FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$0GovernmentGrantsAmt
All Other Contributions$972,121AllOtherContributionsAmt
Noncash Contributions$0NoncashContributionsAmt
Total Contributions$1,713,227TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
Professional Education & Meetings813319$149,500$149,500$0$0
Research Grants813319$10,000$10,000$0$0
Patient & Family Services813319$503,096$503,096$0$0

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$662,596TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$88,364TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$88,364ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$0SecuritiesAmt
Other$0OtherAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$269,268FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$741,106ContriRptFundraisingEventAmt
Fundraising Direct Expenses$217,673FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$51,595TotalRevenueColumnAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$51,595ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,515,782TotalRevenueColumnAmt
Related Or Exempt Func Income$662,596RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$139,959ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$500,000TotalAmt
Program Services$500,000ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$21,523TotalAmt
Program Services$21,523ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$172,175TotalAmt
Program Services$172,175ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$243,560TotalAmt
Program Services$37,471ProgramServicesAmt
Management And General$177,986ManagementAndGeneralAmt
Fundraising$28,103FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$223,704TotalAmt
Program Services$173,472ProgramServicesAmt
Management And General$22,826ManagementAndGeneralAmt
Fundraising$27,406FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$36,441TotalAmt
Program Services$16,257ProgramServicesAmt
Management And General$15,778ManagementAndGeneralAmt
Fundraising$4,406FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$3,174TotalAmt
Management And General$3,174ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$5,800TotalAmt
Management And General$5,800ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$219,667TotalAmt
Program Services$179,712ProgramServicesAmt
Management And General$39,955ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$7,246TotalAmt
Program Services$6,581ProgramServicesAmt
Management And General$332ManagementAndGeneralAmt
Fundraising$333FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$44,011TotalAmt
Program Services$23,870ProgramServicesAmt
Management And General$13,989ManagementAndGeneralAmt
Fundraising$6,152FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$29,597TotalAmt
Program Services$26,091ProgramServicesAmt
Management And General$3,506ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$32,400TotalAmt
Program Services$25,176ProgramServicesAmt
Management And General$5,149ManagementAndGeneralAmt
Fundraising$2,075FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$411,213TotalAmt
Program Services$409,544ProgramServicesAmt
Management And General$1,446ManagementAndGeneralAmt
Fundraising$223FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$5,394TotalAmt
Program Services$1,604ProgramServicesAmt
Management And General$1,580ManagementAndGeneralAmt
Fundraising$2,210FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Bank & Credit Card Processing Fees$10,831$1,545$5,689$3,597
Charity Registration Fees$4,635$0$4,635$0
Dues & Subscriptions$16,002$2,061$9,428$4,513
Other Expenses$41,466$41,466$0$0

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$2,028,839TotalAmt
Program Services$1,638,548ProgramServicesAmt
Management And General$311,273ManagementAndGeneralAmt
Fundraising$79,018FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$479,627BOYAmt
EOY$560,961EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$947,112BOYAmt
EOY$447,978EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$48,530BOYAmt
EOY$54,682EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
EOY$6,472EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$61,105BOYAmt
EOY$11,792EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$4,382,553BOYAmt
EOY$5,167,263EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,918,927BOYAmt
EOY$6,249,148EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$4,702BOYAmt
EOY$37,308EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$247,597BOYAmt
EOY$299,923EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$340,024BOYAmt
EOY$151,143EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$592,323BOYAmt
EOY$488,374EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,225,375BOYAmt
EOY$5,548,913EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$101,229BOYAmt
EOY$211,861EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,326,604BOYAmt
EOY$5,760,774EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,918,927BOYAmt
EOY$6,249,148EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$486,943ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$52,773NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,459,444CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,609,408CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,228,571CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,437,446CurrentTaxYearMinus1YearAmt
Current Tax Year$1,713,227CurrentTaxYearAmt
Total$7,448,096TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,459,444CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,609,408CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,228,571CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,437,446CurrentTaxYearMinus1YearAmt
Current Tax Year$1,713,227CurrentTaxYearAmt
Total$7,448,096TotalAmt
FieldValueIRS element (for citing)
Public Support Total170$7,448,096PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$523CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$42,174CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$16,250CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,151CurrentTaxYearMinus1YearAmt
Current Tax Year$88,364CurrentTaxYearAmt
Total$152,462TotalAmt
FieldValueIRS element (for citing)
Total Support$7,600,558TotalSupportAmt
Public Support CY1700.97994PublicSupportCY170Pct
Public Support PY1700.99031PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$2,352,378TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$52,773NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants$0RecoveriesPriorYearGrantsAmt
Other Revenue$0OtherRevenueAmt
Revenue Not Reported-$52,773RevenueNotReportedAmt
Revenue Subtotal$2,405,151RevenueSubtotalAmt
Investment Expenses Not Incld$0InvestmentExpensesNotIncldAmt
Other Revenues Not Included$110,631OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$110,631RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$2,515,782TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$2,028,839TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$0DonatedServicesUseFcltsAmt
Prior Year Adjustments$0PriorYearAdjustmentsAmt
Losses Reported$0LossesReportedAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$2,028,839ExpensesSubtotalAmt
Investment Expenses Not Incld2$0InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$2,028,839TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part X, Line 2DSF recognizes the effect of tax positions only when they are more than likely than not of being sustained. Management has determined that the foundation has no uncertain tax positions that would require financial statement recognition. Tax years dating back to 2019 remain open to examination by federal and state authorities.
Schedule D, Part XI, Line 4bChange in net assets with donor restrictions

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (including Iceland and Greenland)00Grantmaking$155,845
North America (including Canada and Mexico, but not the United States)00Grantmaking$5,427
East Asia and the Pacific00Grantmaking$3,403
Sub-Saharan Africa00Grantmaking$3,000
Middle East and North Africa00Grantmaking$1,500
South America00Grantmaking$1,500
South Asia00Grantmaking$1,500
FieldValueIRS element (for citing)
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Total Spent$172,175TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEurope (including Iceland and Greenland)RegionTxt
Purpose Of GrantUse of TMS to Understand In-Vivo the Functional Pathophysiology of Dravet Syndrome and Predict Treatment Response- Dr. Balestrini and Dr. Sisodiya will work together on this collaborative effort to use transcranial magnetic stimulation (TMS) to characterize the brain activity patterns of patients with Dravet syndrome. They will compare changes in TMS to patient genotype, responses to treatments, cognitive abilities, and other common symptoms in Dravet syndrome. They will additionally use TMS to better understand how alterations in brain activity may change over time and with age in Dravet syndrome.PurposeOfGrantTxt
Cash Grant$149,845CashGrantAmt
Manner Of Cash DisbursementWire TransferMannerOfCashDisbursementTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (10 entries)

Type Of AssistanceTypeOfAssistanceTxtRegionRegionTxtRecipientRecipientCntCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmtDescription Of Non Cash AsstDescriptionOfNonCashAsstTxtValuation Method UsedValuationMethodUsedDesc
Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network.Europe (including Iceland and Greenland)1$1,500Wire Transfer
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.Europe (including Iceland and Greenland)3$4,500Wire Transfer
Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network.East Asia and the Pacific1$403Items that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation.FMV
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.East Asia and the Pacific2$3,000Wire Transfer
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.Middle East and North Africa1$1,500Wire Transfer
Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network.North America (including Canada and Mexico, but not the United States)3$4,427Items that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation.
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.North America (including Canada and Mexico, but not the United States)1$1,000Wire Transfer
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.South America1$1,500Wire Transfer
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.South Asia1$1,500Wire Transfer
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.Sub-Saharan Africa1$3,000Wire Transfer
FieldValueIRS element (for citing)
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 2FormAndLineReferenceDesc
ExplanationDSF provides funds for research. The organizations receiving this assistance are required to provide written progress reports on their research into finding a cure for Dravet syndrome and related epilepsies. The Scientific Director of DSF reviews the progress reports and discusses the research projects and progress with the awarded organization. DSF also provides funding to patients with Dravet syndrome and related epilepsies for necessary medical equipment, therapy devices and education aids associated with these conditions that are not covered through private insurance or other assistance programs. Applicants are required to submit an application that includes a recent letter from the child's healthcare provider explaining the medical necessity of the request and when possible, a letter of denial from the insurance provider.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1Dance for DravetEvent1Nm
Gross Receipts Event1$463,720GrossReceiptsEvent1Amt
Charitable Contri Event1$340,333CharitableContriEvent1Amt
Gross Revenue Event1$123,387GrossRevenueEvent1Amt
Cash Prizes Event1$0CashPrizesEvent1Amt
Non Cash Prizes Event1$0NonCashPrizesEvent1Amt
Rent Facility Costs Event1$26,528RentFacilityCostsEvent1Amt
Food And Beverage Event1$25,979FoodAndBeverageEvent1Amt
Entertainment Event1$2,050EntertainmentEvent1Amt
Other Direct Expenses Event1$16,605OtherDirectExpensesEvent1Amt
Event2Double Down for Dravet HoustonEvent2Nm
Gross Receipts Event2$151,696GrossReceiptsEvent2Amt
Charitable Contri Event2$110,455CharitableContriEvent2Amt
Gross Revenue Event2$41,241GrossRevenueEvent2Amt
Cash Prizes Event2$0CashPrizesEvent2Amt
Non Cash Prizes Event2$0NonCashPrizesEvent2Amt
Rent Facility Costs Event2$4,763RentFacilityCostsEvent2Amt
Food And Beverage Event2$38,000FoodAndBeverageEvent2Amt
Entertainment Event2$3,599EntertainmentEvent2Amt
Other Direct Expenses Event2$8,897OtherDirectExpensesEvent2Amt
Other Events Total16OtherEventsTotalCnt
Gross Receipts Other Events$394,878GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$290,238CharitableContriOtherEventsAmt
Gross Revenue Other Events$104,640GrossRevenueOtherEventsAmt
Cash Prizes Other Events$0CashPrizesOtherEventsAmt
Non Cash Prizes Other Events$0NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$2,336RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$20,147FoodAndBeverageOtherEventsAmt
Entertainment Other Events$8,585EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$60,184OthDirectExpnssOtherEventsAmt
Gross Receipts Total$1,010,294GrossReceiptsTotalAmt
Charitable Contributions Tot$741,026CharitableContributionsTotAmt
Gross Revenue Total Events$269,268GrossRevenueTotalEventsAmt
Cash Prizes Total Events$0CashPrizesTotalEventsAmt
Non Cash Prizes Total Events$0NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$33,627RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$84,126FoodAndBeverageTotalEventsAmt
Entertainment Total Events$14,234EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$85,686OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$217,673DirectExpenseSummaryEventsAmt
Net Income Summary$51,595NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
The Regents of the University of Michigan
3003 S State StAnn ArborMI48109386006309501(c)(3)$50,000Optimizing the Regional Administration of SCN8a-targeting RNAi Therapy- Dr. Yu's project worked to develop an AAV-delivery for a genetic-based therapy targeting the SCN8A gene. While the majority of cases of Dravet syndrome are caused by mutations in SCN1A, Dr. Yu and the Meisler lab have shown that using genetic-based therapies to reduce expression of the SCN8A gene can compensate for loss-of-function SCN1A-mutations that cause Dravet syndrome.
The Ohio State University
1960 Kenny RoadColumbusOH43210316025986501(c)(3)$150,000Targeting Molecular Responses to Seizures in Dravet Syndrome- Dr. Wagnon's work previously identified that the gene Npas4 is reduced in a mouse model of Dravet syndrome. This project hypothesized that restoration of high Npas4 expression could ameliorate seizures and other symptoms using viral-mediated delivery of Npas4 to the brain of mice with SCN1A haploinsufficiency.
The Washington University
700 Rosedale AvenueSt LouisMO63112430653611501(c)(3)$150,000Ketogenic Diet Modulated Brain Energy Metabolism in Dravet Syndrome- Dr. Thio and Dr. Garbow work together on this collaborative project to better understand the mechanisms whereby the ketogenic diet reduces seizures in Dravet syndrome. They will investigate two metabolic pathways in a genetic mouse model of Dravet syndrome and use neuroimaging techniques to assess these impacts within the brain.
University of Colorado Denver
13001 E 17th Place Room W1124AuroraCO80045846000555501(c)(3)$150,000Lymphoblast Cell Lines as a Model to Uncover Metabolic Defects in Dravet Syndrome- Dr. Patel and Dr. Knupp work together on this collaborative project to establish lymphoblast cell lines from the blood of patients with Dravet syndrome and their unaffected siblings. This library of cell lines will then be used to investigate alterations in energy metabolism that may impact patients with Dravet syndrome as well as stand as a future resource for investigations of new drugs, diets, and treatment responses.
FieldValueIRS element (for citing)
Total501c3 Org4Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescNon Cash AssistanceNonCashAssistanceDesc
Patient Assistance Grants. The DSF Patient Assistance Grant Program offers grants to patients with Dravet syndrome and related epilepsies for necessary medical equipment therapy devices, and educational aids associated with these conditions that are not covered through private insurance or other assistance programs. This program is open to all patients worldwide who are members of the DSF Family Network. The DSF Disaster Relief and Recovery Fund was established for patients with Dravet syndrome that have been impacted by natural and other significant natural disaster events in the U.S., such as tornados, hurricanes, earthquakes. Flooding that results from a significant natural disaster event would also qualify. Families that are members of the DSF Family network may apply for a $500 Visa card or Amazon E-card to be used for lodging, food supplies or however needed.27$4,015$16,008Fair Market ValueItems that are currently covered under this program include: durable medical goods (such as wheelchairs, orthotics, cooling vests, etc.), therapy equipment, communication devices such as iPads, and costs associated with implementation of the ketogenic diet. By awarding these grants, DSF is making no recommendation to the appropriateness or safety of a particular piece of equipment or therapy in treating Dravet syndrome and associated epilepsies and conditions. DSF and its Board of Directors are not responsible for the safety and use of awarded equipment or therapies. Applicants are strongly urged to consult with their medical professionals and therapists regarding equipment and therapies that would be most beneficial for the situation.
Research Grant -Dravet Syndrome International Consensus Project. A core group of pediatric and adult epilepsy specialists, with input from DSF, has identified important clinical issues relating to the diagnosis and management of patients with Dravet syndrome. A international panel consisting of 18-20 experts, consisting of both caregivers as well as neurologists worldwide with particular expertise in managing patients with Dravet syndrome, will be convened. The goal of this study is to utilize a modified Delphi consensus method to establish international best practice treatment guidelines for Clinical presentation and laboratory diagnosis; Antiseizure therapies including medications, dietary, and surgical interventions; Abortive treatments, including status epilepticus management, and transition to adult care; Disease modifying therapies; Comorbidities, SUDEP and mortality; vaccinations.1$1,500

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2FormAndLineReferenceDesc
ExplanationDSF provides funds for research. The organizations receiving this assistance are required to provide written progress reports on their research into finding a cure Dravet syndrome and related epilepsies. The Scientific Director of DSF reviews the progress reports and discusses the research projects and progress with the awarded organization. DSF also provides funding to patients with Dravet syndrome and related epilepsies for necessary medical equipment, therapy devices and education aids associated with these conditions that are not covered through private insurance or other assistance programs. Applicants are required to submit an application that includes a recent letter from the child's healthcare provider explaining the medical necessity of the request and when possible, a letter of denial from the insurance provider.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Mary Anne Meskis
Executive Director$155,000$0$0$0$0$0$0$0$0$0$155,000$0$0$0
Veronica Hood
Scientific Director$151,200$0$0$0$0$0$0$0$0$0$151,200$0$0$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Section B, Line 11bA copy of Form 990 and all related schedules is provided to the executive committee of the board of directors for review prior to filing with the Internal Revenue Service.
Form 990, Part VI, Section B, Line 12cA conflict of interest disclosures statement is distributed and signed by each board member annually. Conflicts are dealt with on a case-by-case basis.
Form 990, Part VI, Section C, Line 19DSF makes its governing documents and conflict of interest policy available to the public upon written request from the president. Financial statements are available for public view on the organization's website.
Form 990, Part IX, Line 11gOther fees for services include Public Relations & Marketing ($172,600), Video Production ($28,450) Graphic Design ($6,163), Consulting ($4,250), Publishing ($3,950), Human Resource ($3,792) and Translation Services ($462).

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.